Caito Maia

Advantages of Bi-layer tablet ( double layer ) . it may compose several cases 1. Separates two incompatible actives to avoid stability problems 2. one layer IR immediate release the second layer CR or SR sustained release 3. one layer IR , second layer CR , Enteric coating 4. one layer IR second layer enteric granules , coating SR ,.... you can formulate further methods depending on your actives and their functionality ...

30

1 comentário

PT | A #HiperRetail é um #Supercharged #Marketplace e vai estar no Porto a apresentar a sua solução ao ecossistema de empreendedores e investidores. #Networking #Investidores #Retalho #Grossistas #Logística EN | #HiperRetail is a #Supercharged #Marketplace and will be in Porto to present its solution to the ecosystem of entrepreneurs and investors. To all those who I haven't seen for a while, let's catch up and have a coffee. #HiperRetail is a marketplace for purchasing food and non-food products, aimed to connect independent wholesalers with independent retailers, HORECA SME's and institutions, aggregating real-time stock and prices from several wholesalers [and a lot of special sauce to make this happen with no friction], guaranteeing a wider range of products, at the best price with free deliveries within 48 hours. Portugal it's just our MVP. HiperRetail - MarketPlace Grossistas Nacionais | www.hiperretail.com Dealroom.co #HiperRetail @ https://lnkd.in/egxJ_Dft #Stockless #Paperless #FrictionlessPayment #Logistic #Delivery #Optimization #SIMConference #MachineLearning #BigData #Analytics #Retail #HORECA #SME #CloudComputing

5

💋🇧🇷 Bigger in Brazil This week the investor-owned skincare maker Galderma announced plans to triple production capacity at the company’s facility in Hortolândia, São Paulo, Brazil. According to a press release (circulated in Portuguese that I read in English thanks to Google Translate), the first phase of the expansion is a US$6.5m investment to purchase both the existing factory, which Galderma previously leased, and the adjoining land. Cetaphil and Dermotivin products manufactured in Hortolândia are sold not only in Latin America but also exported to global markets: the US, Europe, Asia, Africa, and Oceania. Explaining the company’s reasoning for expanding its America’s region manufacturing, Ligia Carla Santos, General Manager of Galderma in Brazil, notes that “Brazil is among the company's three main markets in the world, with a strong growth trajectory in the last year.” “We are proud,” she says in this week’s press release, “to continue investing in the local production of products….With this expansion, we will be able to develop the region's economy and internalize some production processes, improving our speed and flexibility of supply.” “Our goal” says Santos, “is to progress in the Brazilian market, supporting its growth and [dedicate] our focus and passion to our purpose of advancing dermatology—for every skin story.” #skincare #cosmetics #beautyindustry Galderma

171

1 comentário

Today was the day to talk about the influencer market in Brazil. Our numbers, our opportunities, our difficulties and challenges. We have one of the largest markets in the world. Our numbers made this group of MBA students from all countries impressed. Also shared the stage with me, @fabianakaiucaconsultoria who spoke about our marketplace market. Thank you @australgroup for the opportunity and for this space to take our VOICE to the world! Here we go 🚀✅🎉 #influencer #market #influencermarketing #influenciadores #digitalmarketing #contentcreator #marketplace

13

3 comentários

Innovative Medication for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of LMIC/Brazil/LATAM OBJECTIVES: In the context of real-world data on suicide numbers/ cases, we study the chance of a possible decrease in suicide ideation rates, based on scientific data and informations from a promising innovation (esketamine) clinical end point. METHODS: From database of the Notifiable Diseases Information System (SINAN) & Suicide data from the Mortality Information System (SIM) of the year 2022. A total of 496,583 cases of suicide from 2019 to 2022 in Brazilian scenario and a suicide attempt due to exogenous intoxication a subtotal of 4,259 cases, in one specific State (Pernambuco). Data from international literature showing esketamine intranasal and antidepressant treatment decreased: the risk of relapse by 51% (Hazard Ratio [HR], 0.49; 95% ci, 0.29-0.84) among patients who achieved stable remission, and 70% (HR, 0.30; 95% ci, 0.16-0.55) among those who achieved stable response compared to treatment with antidepressants and placebo. RESULTS: We speculate that 51% (Hazard Ratio [HR] of 496,583 CASES, means that esketamine and antidepressant treatment decreased the risk of relapse to avoidance risk of suicidal ideation in 253.257 cases. The 2,172 / 4,259 cases of attempted suicide reported in exogenous intoxication data, could contemplate the chances of rescue from “de novo" treatments and better clinical outcomes. CONCLUSIONS: For patients who have experienced remission or response after treatment with esketamine, there is a chance to resume a new treatment protocol in order to avoid loss of life or loss of productivity in cases of sequelae/suicide attempt. However, lengthy follow-up is needed in order to answer to this, with regard to economic impact and other outcomes.

18

Inteligência Artificial no Marketing.

24

1 comentário

Last 25 of April MJV Technology & Innovation gathered the biggest health companies in Brazil for a brief discussion on #health and #technology. The event was named MJV Rethink Health. Here are some of the things technology is doing in this field, they are mind-blowing. Medical Imaging: AI algorithms are used to analyze medical images such as X-rays, MRIs, and CT scans to assist radiologists in diagnosing diseases like cancer, fractures, and abnormalities. AI can help in detecting patterns and anomalies that might be missed by human eyes, thus improving diagnostic accuracy and speed. Drug Discovery and Development: AI is used in pharmaceutical research to accelerate drug discovery and development processes. Machine learning algorithms can analyze vast amounts of biomedical data to identify potential drug candidates, predict their efficacy, and optimize clinical trial designs, ultimately reducing the time and cost involved in bringing new drugs to market. Personalized Medicine: AI algorithms can analyze individual patient data, including genetic information, medical history, and lifestyle factors, to tailor treatment plans and predict patient outcomes more accurately. Healthcare Administration: AI-powered tools are streamlining administrative tasks in healthcare facilities, such as patient scheduling, billing, and medical coding. Natural language processing (NLP) algorithms can automate documentation processes by converting spoken or written medical notes into structured data, reducing paperwork and administrative burdens on healthcare professionals. Telemedicine and Remote Monitoring: AI technologies are facilitating the expansion of telemedicine services and remote patient monitoring solutions. Virtual health assistants powered by AI can provide patients with personalized medical advice, reminders, and support, while wearable devices equipped with AI algorithms can continuously monitor vital signs and detect early signs of health deterioration. Predictive Analytics and Preventive Care: AI algorithms can analyze large datasets of patient health records to identify patterns and trends that may indicate potential health risks or outbreaks of diseases. By leveraging predictive analytics, healthcare providers can intervene proactively to prevent adverse health events and improve population health outcomes. Healthcare Robotics: AI-driven robots are being deployed in healthcare settings to assist with tasks such as medication delivery, patient monitoring, and surgical assistance. AI-powered clinical decision support systems (CDSS) are helping healthcare providers make evidence-based treatment decisions by integrating patient data, medical literature, and clinical guidelines. They can suggest diagnostic tests, recommend treatment options, and alert clinicians to potential drug interactions or adverse events, improving patient safety and quality of care. Pretty awesome :-) #ai

2

2 comentários

This publication on the 1st Cleft Summit reflects the power of collaborative voices in fostering a unified approach for the management of complex issues & challenges facing the provider community globally. There is always power in unity.

29

2 comentários

O Padrinho da IA, Geoffrey Hinton, revela o futuro da humanidade: Prepare-se para o que vem por aí! Contribuições e preocupações de Geoffrey Hinton: Geoffrey Hinton, conhecido como "O Padrinho da IA", desempenhou um papel crucial no desenvolvimento da IA avançada através de redes neurais. Embora acredite que a IA tenha o potencial de fazer um bem imenso, ele alerta que os sistemas de IA poderiam se tornar mais inteligentes do que os humanos e possivelmente assumir o controle.  1.- Capacidades de aprendizado da IA: Hinton explica que os sistemas de IA aprendem através de redes neurais que fortalecem conexões corretas e enfraquecem as incorretas. Esses sistemas, como chatbots e robôs, podem se auto-ensinar e tomar decisões, às vezes de maneiras que não são totalmente compreendidas por seus criadores.  2.- Riscos potenciais da IA: Hinton destaca vários riscos associados à IA, incluindo desemprego devido à automação, notícias falsas, algoritmos tendenciosos e a possibilidade de robôs militares autônomos. Ele enfatiza a necessidade de regulamentações e um tratado global para proibir robôs militares.  3.- Inteligência atual e futura da IA: Hinton acredita que os sistemas de IA já demonstram inteligência e compreensão significativas, potencialmente superando a inteligência humana no futuro. Ele menciona que a capacidade da IA de raciocinar e entender a linguagem já é evidente em chatbots avançados como o GPT-4.  4.- Chamado para cautela e regulamentação: Fazendo um paralelo com a era pós-bomba atômica de Robert Oppenheimer, Hinton insta o mundo a considerar cuidadosamente o desenvolvimento e a regulamenta��ão da IA. Ele defende a realização de experimentos para entender melhor a IA e implementar regulamentações governamentais para garantir a segurança e o controle sobre essas poderosas tecnologias.  #GeoffreyHinton #InteligênciaArtificial #RedesNeurais #RiscosDaIA #RegulamentaçãoDaIA #GPT4 #AprendizadoDeMáquina #Automação #NotíciasFalsas #RobôsMilitares #DesenvolvimentoDaIA #Inovação #Tecnologia #FuturoDaIA #SegurançaDaIA

3

Healthcare in Brazil is a $200B market. Broken, inefficient and extraordinary complex 🤯 Today we are digging in the story of Alice, one of Brazil's largest health tech startups, backed by the likes of KASZEK, SoftBank Latin America Fund, Globo Ventures, MAYA CAPITAL, Canary, Endeavor Catalyst and ThornTree Capital Partners and Allen & Company LLC. 👇🏻 For this week’s episode of The J Curve I sat down with André Florence and Guilherme [Gui] Azevedo, Endeavor entrepreneurs and co-founders at Alice. Prior to launching Alice, Andre was a CFO at Brazilian first-known tech unicorn 99 and led the company through the acquisition by Chinese Didi; and Gui was a co-founder of a chain of healthcare clinics dr.consulta. We discuss 👇🏻 1️⃣ Alice partnership playbook: how to build a co-founder relationship that lasts? 2️⃣ Growth at all cost is dead: five lessons learned from pivoting towards efficiency 3️⃣ The vicious cycle: why healthcare innovation is broken in Brazil and how tech natives can fix it?  4️⃣ Fasten your seatbelts: how to build a resilient startup culture in a volatile market? 5️⃣ Breaking the mold: the biggest challenges of challenging the status quo industries Watch / listen to the episode by tuning into The J Curve podcast on 👇 Youtube 👀 ===> https://lnkd.in/e2NkfkS2 Spotify 🎙===> https://lnkd.in/eAdG-aXy Apple Podcast 🍏 ===> https://lnkd.in/eepvjPnd Please enjoy this wide-ranged conversation!

84

7 comentários

Analise preditiva com health indicator? Sim temos!

9

It's gratifying to see the crypto universe and innovation becoming increasingly part of people's lives, especially in important areas like culture. The immersive exhibition "Decade of the Oceans - 1st National Cryptart Exhibition" has been at the CCBB - Centro Cultural Banco do Brasil in São Paulo since March 27, bringing together innovation, technology, and art. The theme was defined in partnership with the UN regarding the Decade of the Oceans, which runs from 2021 to 2030. Events like this show how Blockchain is increasingly present in our daily lives, becoming an accessible means of promoting culture. Here at WEB3DEV, we understand this role and want to bring more knowledge about this decentralized universe! If you want to learn more about Blockchain, we have a study group every Tuesday at 7 pm in our Discord community! https://lnkd.in/dW5qVMJR

2

❌ "If you're not ready to embrace risk and uncertainty, don't quit your 9 to 5." ❌ 🌟 The journey from idea to reality is filled with challenges, but it's also incredibly rewarding. In my latest article, I share valuable insights from my experience launching Veja Obra, including: Embracing risk and uncertainty: You will never have all the information you need. Learn to make the best decision with what you have and live with the outcomes. Building resilience and adaptability: Setbacks are part of the process. Stay focused, adapt, and keep moving forward. Creating a scalable business model: Ensure your growth doesn't come with a proportional increase in costs. 💬 "The only way is through. Keep grinding, keep learning, and enjoy the ride." What's the biggest challenge you've faced in your entrepreneurial journey? Share your stories and let's learn from each other! 📢 Let’s spark a conversation and help each other excel in our entrepreneurial ventures! 🔗 Read the full article here [ https://shorturl.at/aNjs6 ] #Startup #Entrepreneurship #BusinessGrowth #RiskManagement #Resilience #ScalableBusiness

2